AviadoBio

#ICYMI: Last week, we announced our exclusive option-license agreement with UgeneX Therapeutics Co., Ltd. to develop UGX-202, an investigational #GeneTherapy for people living with #RetinitisPigmentosa (RP) and other retinal diseases. This collaboration highlights the strength of our shared vision in advancing innovative science with the potential to restore vision and improve lives. Thank you to both teams for their dedication to expanding the possibilities of gene therapy and optogenetics. Learn more: https://lnkd.in/d4vDsfF2 #Biotech #Optogenetics

Interested in learning more about how our innovative #GeneTherapy delivery method bypasses the blood-brain barrier for precise dosing in the brain?    Watch below to see how we administer our investigational gene therapy directly to the thalamus through a specialized neurosurgical procedure.    #Biotech

#ICYMI: #TeamAviadoBio presented four posters at the European Society of Gene and Cell Therapy Congress, highlighting some of our latest research updates. 💡Interested in learning more about how we’re progressing our work in #GeneTherapy? Check out the posters on our website: https://lnkd.in/dscTMjpU

We’re thrilled to announce we have entered into a partnership with UgeneX Therapeutics Co., Ltd., to develop next generation optogenetics gene therapy (UGX-202) with the potential to restore vision in patients with retinitis pigmentosa (RP) and other retinal diseases. UGX-202 represents an exciting step forward in AviadoBio’s mission to deliver targeted, potentially life-changing medicines, expanding our impact into optogenetics to reach patients urgently needing new treatment options. Learn more: https://lnkd.in/d4vDsfF2 #GeneTherapy #RetinitisPigmentosa #Biotech #Optogenetics

Join our CEO, Lisa Deschamps at #CGMesa25 today as she provides a company update and dives into our mission to relentlessly chase cures for neurodegenerative diseases through precision #GeneTherapy.    👉 Explore our pipeline: https://lnkd.in/eaHcq4pe     #Biotech Alliance for Regenerative Medicine 

Are you attending the European Society of Gene and Cell Therapy Congress? Let’s connect!    Our team will be on-site presenting four posters and available for meetings - Amrita Abhilash, Rebecca Lyth, Emily Dellow, Leonie Brebner, Carlos Miranda   Looking forward to seeing you in Seville and discussing the latest updates in #GeneTherapy.    Learn more about our presentation here https://lnkd.in/drQrDA8z    #ESGCT2025

📢 Heading to #CGMesa25?     Don’t miss our CEO, Lisa Deschamps, in the panel session next week: “Equity at Scale: Expanding Access to Cell and Gene Therapies Across Borders.”    Lisa will join fellow leaders across the sector to discuss how we can expand global access to #CGTs.     🔗 Full details: https://lnkd.in/eRmZKkd5     #GeneTherapy #Biotech     Alliance for Regenerative Medicine 

We’re honored to sponsor the upcoming “Demenza Frontotemporale: riconoscere, curare e accompagnarethe” hosted by Fatebenefratelli - Provincia Lombardo Veneta Lombardo Veneta who are dedicated to advancing understanding and care for people living with #FrontotemporalDementia (#FTD).    This important gathering brings together global experts in Brescia, Italy, to share the latest research, clinical insights, and innovations in FTD diagnosis and treatment.    Università degli Studi di Brescia AIMFT, Associazione Italiana Malattia Frontotemporale 

We’re pleased to share that AviadoBio has been named a finalist in the European Lifestars Awards’ Women-Led Business of the Year and CEO of the Year categories! These nominations recognize the work #TeamAviadoBio has done under Lisa Deschamps' leadership in advancing AviadoBio, the #FTD community and the broader life sciences sector. We’re honored to be considered among so many inspiring leaders driving progress in life sciences. European Lifestars Awards - Celebrating Life Science Leaders #EuropeanLifestars #Biotech

Last week during World FTD Awareness Week, it was time to shine a light on #FrontotemporalDementia, highlighting the role we can play as a team in raising awareness and driving meaningful conversations.    At AviadoBio, we believe team building is about building empathy, resilience, and awareness together. Our mission to #endFTD remains the focus of our team.  #FTD